Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Zilurgisertib fumarate by Incyte for Multiple Myeloma (Kahler Disease): Likelihood of Approval
Zilurgisertib fumarate is under clinical development by Incyte and currently in Phase II for Multiple Myeloma (Kahler Disease). According to...
Zilurgisertib fumarate by Incyte for Myelofibrosis: Likelihood of Approval
Zilurgisertib fumarate is under clinical development by Incyte and currently in Phase II for Myelofibrosis. According to GlobalData, Phase II...
Zilurgisertib fumarate by Incyte for Anemia: Likelihood of Approval
Zilurgisertib fumarate is under clinical development by Incyte and currently in Phase II for Anemia. According to GlobalData, Phase II...
Zilurgisertib fumarate by Incyte for Myelodysplastic Syndrome: Likelihood of Approval
Zilurgisertib fumarate is under clinical development by Incyte and currently in Phase II for Myelodysplastic Syndrome. According to GlobalData, Phase...